(CELH) Celsius Holdings - Ratings and Ratios
Functional Energy Drinks, Hydration Powders, Ready-To-Drink
CELH EPS (Earnings per Share)
CELH Revenue
Description: CELH Celsius Holdings October 30, 2025
Celsius Holdings, Inc. (NASDAQ: CELH) designs, manufactures, markets and distributes a portfolio of functional energy and hydration beverages-including CELSIUS Originals, Vibe, Essentials, On-the-Go Powder, and Hydration powders-across the United States, North America, Europe, Asia-Pacific and other international markets. Distribution channels span direct-to-store delivery, independent distributors, supermarkets, convenience and drug stores, specialty nutrition retailers, food-service operators, gyms, mass-market chains and e-commerce platforms.
Recent performance highlights include FY 2023 net revenue of approximately $1.8 billion, representing a 45 % year-over-year increase driven largely by strong volume growth in the on-premise (gym and fitness-center) segment and expanding e-commerce sales. The brand’s “zero-sugar, thermogenic” positioning aligns with the broader health-conscious beverage trend, which the Beverage Marketing Corporation estimates will sustain a CAGR of ~5 % through 2027. However, competitive pressure from larger soft-drink conglomerates and the need for continuous innovation in flavor and functional claims remain material risk factors.
For a deeper quantitative view of CELH’s valuation metrics and scenario analysis, you may find the ValueRay platform useful.
CELH Stock Overview
| Market Cap in USD | 15,354m |
| Sub-Industry | Soft Drinks & Non-alcoholic Beverages |
| IPO / Inception | 2007-02-02 |
CELH Stock Ratings
| Growth Rating | 63.1% |
| Fundamental | 75.2% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 21.3% |
| Analyst Rating | 4.0 of 5 |
CELH Dividends
Currently no dividends paidCELH Growth Ratios
| Growth Correlation 3m | 22.2% |
| Growth Correlation 12m | 91.4% |
| Growth Correlation 5y | 69.1% |
| CAGR 5y | 10.19% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.13 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.30 |
| Sharpe Ratio 12m | 0.44 |
| Alpha | 13.48 |
| Beta | 0.971 |
| Volatility | 51.21% |
| Current Volume | 23524.2k |
| Average Volume 20d | 3486k |
| Stop Loss | 38.6 (-7%) |
| Signal | 1.08 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (131.8m TTM) > 0 and > 6% of Revenue (6% = 100.0m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -8.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 43.89% (prev 71.95%; Δ -28.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 235.7m > Net Income 131.8m (YES >=105%, WARN >=100%) |
| Net Debt (247.7m) to EBITDA (189.6m) ratio: 1.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (237.2m) change vs 12m ago -0.18% (target <= -2.0% for YES) |
| Gross Margin 50.53% (prev 50.45%; Δ 0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.45% (prev 86.68%; Δ -26.23pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.58 (EBITDA TTM 189.6m / Interest Expense TTM 18.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.04
| (A) 0.19 = (Total Current Assets 1.39b - Total Current Liabilities 659.8m) / Total Assets 3.80b |
| (B) 0.06 = Retained Earnings (Balance) 236.2m / Total Assets 3.80b |
| (C) 0.06 = EBIT TTM 173.3m / Avg Total Assets 2.76b |
| (D) 0.14 = Book Value of Equity 238.4m / Total Liabilities 1.70b |
| Total Rating: 2.04 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.20
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 1.35% = 0.68 |
| 3. FCF Margin 12.65% = 3.16 |
| 4. Debt/Equity 0.41 = 2.42 |
| 5. Debt/Ebitda 1.31 = 1.30 |
| 6. ROIC - WACC (= 6.57)% = 8.22 |
| 7. RoE 9.04% = 0.75 |
| 8. Rev. Trend 72.92% = 5.47 |
| 9. EPS Trend 44.08% = 2.20 |
What is the price of CELH shares?
Over the past week, the price has changed by -31.06%, over one month by -32.00%, over three months by -17.16% and over the past year by +38.35%.
Is Celsius Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CELH is around 47.17 USD . This means that CELH is currently undervalued and has a potential upside of +13.61% (Margin of Safety).
Is CELH a buy, sell or hold?
- Strong Buy: 8
- Buy: 6
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CELH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.1 | 66.3% |
| Analysts Target Price | 69.1 | 66.3% |
| ValueRay Target Price | 52.9 | 27.4% |
CELH Fundamental Data Overview November 06, 2025
P/E Trailing = 156.7369
P/E Forward = 39.8406
P/S = 9.2132
P/B = 11.9854
P/EG = 0.966
Beta = 0.971
Revenue TTM = 1.67b USD
EBIT TTM = 173.3m USD
EBITDA TTM = 189.6m USD
Long Term Debt = 862.9m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 862.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 247.7m USD (from netDebt column, last quarter)
Enterprise Value = 15.60b USD (15.35b + Debt 862.9m - CCE 615.2m)
Interest Coverage Ratio = 9.58 (Ebit TTM 173.3m / Interest Expense TTM 18.1m)
FCF Yield = 1.35% (FCF TTM 210.8m / Enterprise Value 15.60b)
FCF Margin = 12.65% (FCF TTM 210.8m / Revenue TTM 1.67b)
Net Margin = 7.91% (Net Income TTM 131.8m / Revenue TTM 1.67b)
Gross Margin = 50.53% ((Revenue TTM 1.67b - Cost of Revenue TTM 824.4m) / Revenue TTM)
Gross Margin QoQ = 51.52% (prev 52.35%)
Tobins Q-Ratio = 4.11 (Enterprise Value 15.60b / Total Assets 3.80b)
Interest Expense / Debt = 2.10% (Interest Expense 18.1m / Debt 862.9m)
Taxrate = 22.87% (29.6m / 129.5m)
NOPAT = 133.7m (EBIT 173.3m * (1 - 22.87%))
Current Ratio = 2.11 (Total Current Assets 1.39b / Total Current Liabilities 659.8m)
Debt / Equity = 0.41 (Debt 862.9m / totalStockholderEquity, last quarter 2.09b)
Debt / EBITDA = 1.31 (Net Debt 247.7m / EBITDA 189.6m)
Debt / FCF = 1.17 (Net Debt 247.7m / FCF TTM 210.8m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.47% (Net Income 131.8m / Total Assets 3.80b)
RoE = 9.04% (Net Income TTM 131.8m / Total Stockholder Equity 1.46b)
RoCE = 7.47% (EBIT 173.3m / Capital Employed (Equity 1.46b + L.T.Debt 862.9m))
RoIC = 15.74% (NOPAT 133.7m / Invested Capital 849.1m)
WACC = 9.17% (E(15.35b)/V(16.22b) * Re(9.59%) + D(862.9m)/V(16.22b) * Rd(2.10%) * (1-Tc(0.23)))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF Debug] Terminal Value 69.59% ; FCFE base≈224.9m ; Y1≈189.6m ; Y5≈142.9m
Fair Price DCF = 7.88 (DCF Value 2.03b / Shares Outstanding 257.8m; 5y FCF grow -19.02% → 3.0% )
EPS Correlation: 44.08 | EPS CAGR: 444.4% | SUE: 1.53 | # QB: 1
Revenue Correlation: 72.92 | Revenue CAGR: 64.45% | SUE: 3.19 | # QB: 1
Additional Sources for CELH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle